The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

In a 2020 meta-analysis of 30 studies, researchers found that RSV was the most common viral co-infection among hospitalized COVID patients. What does this mean for you in practice? Well ...

Dr. Julie Holland, a pediatrician at Advocate Children's Hospital joined the WGN Evening News at 4 p.m. to discuss the dangers of RSV as people travel and gather with family for the holidays.

Two RSV vaccines – Pfizer Abrysvo and GSK Arexvy – were approved in 2023 by the Food and Drug Administration for adults ages 60 and older. However, this doesn’t mean all adults in this age ...

MANILA, Philippines — Respiratory Syncytial Virus (RSV) is a common, contagious virus affecting the lungs and breathing passages. It usually causes mild, cold-like symptoms that are often ...

If you're feeling unwell this season, it may not be easy to tell exactly what is making you sick; multiple viruses are circulating in Michigan this winter, making vaccination and healthy habits ...

NHS England announced on Monday that more than one million adults in England, aged between 75 and 79, or those who turned 80 after September 1, will be invited to receive the RSV jab over the next few ...

The most common isolated agent is respiratory syncytial virus (RSV). Our aim was to investigate the infectious agents, clinical management and length of stay in hospital of babies with bronchiolitis.